Lionsgate Studios director Mark Rachesky reports large share transfers By Investing.com

NEW YORK – Mark H. Rachesky, a Director and Ten Percent Owner of Lionsgate Studios Corp. (NASDAQ: LION), reported significant transactions involving the company’s common shares on July 8, 2026, according to a recent SEC Form 4 filing. These transactions were part of a complex continuation fund transaction and did not involve cash sales or purchases. The restructuring comes as Lionsgate shares trade at $13.47, giving the entertainment company a market capitalization of $3.92 billion. The stock has delivered impressive returns of 92% over the past year, though InvestingPro analysis suggests the shares are currently trading above their Fair Value.

In a series of dispositions on July 8, Dr. Rachesky indirectly transferred a total of 42,500,497 common shares. These transactions, which were part of the continuation fund transaction, were reported with a price of $0.0 per share and a total dollar value of $0.0. The dispositions included:

1,469,450 common shares that were contributed from MHR Institutional Partners II to Sun II and LION Holdco A.

3,701,988 common shares that were contributed from MHR Institutional Partners IIA to Sun IIA and LION Holdco B.

25,173,882 common shares that were contributed from MHR Institutional Partners III to Sun III and LION Holdco B.

499,765 common shares that were contributed from LION Holdco A to LION SubHoldco A.

11,755,412 common shares that were contributed from LION Holdco B to LION SubHoldco B.Despite the strong stock performance, Lionsgate faces financial challenges with a negative earnings per share of $0.64 over the last twelve months and total debt of $4.19 billion against revenue of $2.63 billion. InvestingPro assigns the company a “FAIR” financial health score and identifies it among overvalued stocks in the market. Investors can access detailed analysis through the comprehensive Pro Research Report, available for LION and 1,400+ other US equities, which transforms complex Wall Street data into clear, actionable intelligence.

Concurrently, Dr. Rachesky indirectly acquired a total of 42,600,497 common shares through various contributions and exchanges related to the same continuation fund transaction. These acquisitions were also reported with a price of $0.0 per share and a total dollar value of $0.0. The acquisitions included:

797,526 common shares acquired for the account of MHR Sun II LP.

1,916,271 common shares acquired for the account of MHR Sun IIA LP.

11,154,680 common shares acquired for the account of MHR Sun III LP.

671,924 common shares acquired for the account of MHR LION Holdco A LP.

499,765 common shares acquired for the account of MHR LION SubHoldco A LP.

15,804,919 common shares acquired for the account of MHR LION Holdco B LP.

11,755,412 common shares acquired for the account of MHR LION SubHoldco B LP.

The filing indicates that these share movements were part of a “continuation fund transaction” (referred to as the “CV Transaction” in the filing footnotes), where shares were contributed to various entities in exchange for limited partnership interests or other interests. This explains why no cash price per share or total dollar value is reported for these specific share movements.

Following these transactions, Dr. Rachesky’s direct holdings include 262,212 common shares and 20,107 restricted share units, which are scheduled to vest in November 2026. His indirect beneficial ownership of Lionsgate Studios common shares is distributed across several entities, including MHR Capital Partners Master Account LP, MHR Capital Partners (100) LP, MHR Institutional Partners IV LP, MHR LION Holdco A LP, MHR LION Holdco B LP, MHR LION SubHoldco A LP, and MHR LION SubHoldco B LP, among others. Dr. Rachesky, through affiliated entities, disclaims beneficial ownership of these common shares except to the extent of his pecuniary interest therein.

In other recent news, trading activity in Lionsgate Studios options has seen a significant increase, with a total of 21,646 contracts traded. Of these, call options accounted for 18,828 contracts, while put options totaled 2,818 contracts. The most notable single position was the July 17, 2026, $18 call, which had 6,409 contracts against an open interest of 5 contracts. These developments indicate heightened interest in Lionsgate Studios from investors. While the trading data does not include specific earnings or revenue results, the substantial options activity suggests that market participants are actively positioning themselves in anticipation of future events. Analyst opinions or ratings were not mentioned in the recent updates. Investors should continue to monitor for any forthcoming earnings announcements or analyst reports for more detailed insights.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.